Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
Concept/Terms
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in Harvard Catalyst Profiles by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 2 | 2 |
1995 | 1 | 0 | 1 |
1996 | 2 | 0 | 2 |
1997 | 0 | 1 | 1 |
1998 | 2 | 1 | 3 |
1999 | 3 | 1 | 4 |
2000 | 3 | 0 | 3 |
2001 | 1 | 0 | 1 |
2002 | 1 | 2 | 3 |
2003 | 5 | 0 | 5 |
2004 | 2 | 0 | 2 |
2005 | 0 | 2 | 2 |
2006 | 3 | 0 | 3 |
2007 | 4 | 1 | 5 |
2008 | 4 | 1 | 5 |
2009 | 7 | 2 | 9 |
2010 | 4 | 3 | 7 |
2011 | 5 | 0 | 5 |
2012 | 8 | 1 | 9 |
2013 | 8 | 1 | 9 |
2014 | 14 | 2 | 16 |
2015 | 13 | 0 | 13 |
2016 | 8 | 2 | 10 |
2017 | 20 | 1 | 21 |
2018 | 16 | 2 | 18 |
2019 | 28 | 3 | 31 |
2020 | 29 | 3 | 32 |
2021 | 37 | 3 | 40 |
2022 | 40 | 1 | 41 |
2023 | 35 | 0 | 35 |
2024 | 13 | 0 | 13 |
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Inhaled treprostinil in patients with pulmonary hypertension associated with interstitial lung disease with less severe haemodynamics: a post hoc analysis of the INCREASE study. BMJ Open Respir Res. 2024 Mar 22; 11(1).
-
Survival analysis from the INCREASE study in PH-ILD: evaluating the impact of treatment crossover on overall mortality. Thorax. 2024 Mar 15; 79(4):301-306.
-
Nintedanib Therapy Alone and Combined with Mycophenolate in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: Systematic Reviews and Meta-analysis. Ann Am Thorac Soc. 2024 Mar; 21(3):474-485.
-
Characterisation of airway disease associated with Sjögren disease. RMD Open. 2024 Feb 29; 10(1).
-
Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2024 Feb; 21(2):317-327.
-
Pulmonary Pathology Society Survey on Practice Approaches in the Histologic Diagnosis of Fibrotic Interstitial Lung Disease: Consensus and Opportunities. Arch Pathol Lab Med. 2024 Feb 01; 148(2):168-177.
-
Tocilizumab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease: A Systematic Review and Meta-Analysis. Ann Am Thorac Soc. 2024 Feb; 21(2):328-337.
-
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 01 18; 79(2):182-185.
-
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):137-152.
-
The impact of hospitalization on mortality in patients with connective tissue disease-associated interstitial lung disease: a medical records review study. Adv Rheumatol. 2024 Jan 02; 64(1):1.